GlassScriptPhysician profile
Michael J Woods
NPI 1598702128
$1,632.19
in general payments reported to CMS, 2019-2025
26 companies · $85.08 in 2025
The $85.08 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $142 · 2021: $230 · 2022: $93.46 · 2023: $320 · 2024: $331 · 2025: $85.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $220.92 | 2022-2024 | Painteq |
| Spr Therapeutics, INC | $166.35 | 2023-2024 | Sprint Pns System |
| Bioventus LLC | $151.40 | 2019-2023 | Durolane |
| Assertio Therapeutics, INC. | $127.92 | 2019-2020 | |
| Si-Bone, INC. | $125.00 | 2021 | |
| Scilex Pharmaceuticals INC. | $118.25 | 2019-2020 | |
| Djo, LLC | $70.94 | 2023 | Chattanooga |
| Medtronic, INC. | $69.99 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Pfizer INC. | $51.89 | 2019-2020 | |
| Nevro Corp. | $47.44 | 2023 | Senza |
| Radius Health, INC. | $46.24 | 2019 | |
| Redhill Biopharma INC. | $44.70 | 2021 | |
| Abbott Laboratories | $44.07 | 2019 | |
| Pacira Therapeutics, INC. | $43.45 | 2019 | |
| Relievant Medsystems, INC. | $42.12 | 2022-2023 | Intracept |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $41.79 | 2019 | |
| Azurity Pharmaceuticals, INC. | $30.99 | 2025 | Horizant |
| Biodelivery Sciences International, INC. | $26.97 | 2019-2020 | |
| Abbvie INC. | $24.46 | 2023 | Botox |
| Averitas Pharma INC. | $24.45 | 2023 | Qutenza |
| Nalu Medical, INC. | $23.82 | 2024 | Nalu Neurostimulation System |
| Ibsa Pharma INC. | $23.61 | 2022 | |
| Curonix LLC | $18.17 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $17.30 | 2025 | Ha Minuteman G3-R |
| Depuy Synthes Sales INC. | $15.79 | 2024 | Orthovisc, Monovisc |
| Vertex Pharmaceuticals Incorporated | $14.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.